BOSTON — Massachusetts is getting $17 million as part of a multi-state settlement with opioid manufacturers over their alleged role in fueling a nationwide drug epidemic.

Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated urinary tract infections ...

For more information, contact David Cobb, Alembic Pharmaceuticals [email protected] 908-552-583 SOURCE: Utility Therapeutics Ltd. View the original press release on ACCESS Newswire ...

In trading on Tuesday, shares of Catalyst Pharmaceuticals Inc (Symbol: CPRX) entered into oversold territory, hitting an RSI reading of 29.7, after changing hands as low as $21.1648 per share.

The Boston Arts Academy Foundation closed its Building Our Future fundraising campaign, surpassing its $35 million goal, thanks to twin $1 million donations – one from Vertex Pharmaceuticals ...

In June 2023, Boston Pharmaceuticals released positive Phase IIa results for BOS-580, its investigational, proprietary, long-acting fibroblast growth factor 21 (FGF21) analog for the treatment of ...

Is extreme heat the new normal in Boston? If the heat across Massachusetts this week felt unbearable, you're not imagining it. Boston hit 102 degrees on Tuesday.